Tardive Dyskinesia Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
SKU : HCIT3685
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Tardive Dyskinesia Treatment Market ?
Tardive Dyskinesia Treatment Market is expected to grow at a CAGR of 4% during the forecast period 2024-2031.
Who are the key players in Tardive Dyskinesia Treatment Market ?
Major players are Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Biogen, Novartis AG, Johnson & Johnson Services, Inc., AstraZeneca, GlaxoSmithKline plc., Bayer AG,  Sanofi, Shanghai Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical GroupCo., Ltd. and Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.